After three cycles of DSS administration, mice with colitis showed reduced colon length (a marker of intestinal inflammation) as well as increased levels of DAI, MDA (a measure of the colonic oxidative insult), MPO (an index of neutrophil accumulation), and inflammatory factors (IL-1β and IL-6) (Figure 6B,C,D). Here, IL1B is linked to colitis.